Macroaxis: Personalized Investing  
Macroaxis Country Selector USA  Change      Macroaxis User Registration Register    Macroaxis User Login Sign In
   
 US Market Closed: Mar 15, 22:19 PM 2010 
  NYSE  7350.96  11.89  Index Moved Down   NASDAQ  2362.21  5.45  Index Moved Down  		Search is sponsered by    
  



Processing
Collecting necessary data for SLXP...

Salix Pharmaceuticals Ltd. financials, fundamentals and performance

    
30.82
Intraday
 
One Month
(1.14)  Macroaxis: -3.57 Down   3.57%  
    
Salix Pharmaceuticals Ltd. is Bearish SLXP Salix Pharmaceuticals Ltd.
 Trade It Now
 
    
Macroaxis: United States NASDAQ
    
Market Cap 1.608B   Book Value 7.093   EBITDA -27.2M   Year Low 7.33   Year High 32.03   PEG Ratio 6.84   EPS -0.884   P/B Ratio 4.51   Short Ratio 3.30   Index Membership S&P 600 SmallCap   S&P    Sector Healthcare   Industry Drug Related Products   Open 31.75   High 31.96   Low 30.63   Last Close 31.96   Volume 941.1 K   Target Price 41.33   Current EPS -0.884   This Year EPS 0.11   Next Year EPS 1.46   This Year PE 290.55   Next Year PE 21.89  

30-Days Risk-Return Take

    
SalixRisk FreeMarket
    

Profile

    
Suggest       

Today

  
Salix Pharmaceuticals, Ltd. acquires, develops, and commercializes prescription drugs for the treatment of gastrointestinal disorders in the United States.
 Macroaxis: United States GSPC   0.05 % Price Moved Up  
 
 Macroaxis: United States NYA   0.16 % Price Moved Down  
 
 Macroaxis: United States IXIC   0.23 % Price Moved Down  
 
 Macroaxis: thisRed SLXP   3.57 % Price Moved Down  
 
    
    
    

Performance    Embed Financials

    
    
 Embed Financials
 Compare Salix To   
    
Perrigo  NBTY  Herbalife  Auxilium  USANA  Prestige  CHBT  China  Schiff  BJGP  Tiens  NUTR  Mannatech  Natural  Medical  Cyanotech 
 Risk & Return  Correlation
    

30-Days Moving Rating

    

Macroaxis Total Score 

    
3
Embed Financials
Current 30 Days Moving Rating
MedicalSalixNUTRPrestigeAuxilium
    
SLXP financials 

Current Net Investing Interest   

 
 0 
    

Estimated Market Risk

 5.48
  actual daily
 
 24 %
of total potential
 
Market Risk score

Expected Return

 0.79
  actual daily
 
 33 %
of total potential
 
Expected Return score

Risk-Adjusted Return

 0.14
  actual daily
 
 7 %
of total potential
 
Risk-Adjusted Return score
Based on monthly moving average   [ change ] 
Increase Risk-Adjusted return of SLXP by adding it to a well-diversified portfolio
Diversify
    

 Last Intraday

    
 
(1.14)Macroaxis: -1.14 Up3.57%
 
31.96,31.96,30.82,30.82,31.96,30.63,30.82
 
31.9630.82
    

Partner Center